These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16023673)

  • 1. Oxidative refolding of amyloidogenic variants of human lysozyme.
    Wain R; Smith LJ; Dobson CM
    J Mol Biol; 2005 Aug; 351(3):662-71. PubMed ID: 16023673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants.
    Canet D; Sunde M; Last AM; Miranker A; Spencer A; Robinson CV; Dobson CM
    Biochemistry; 1999 May; 38(20):6419-27. PubMed ID: 10350460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the dominant oxidative folding intermediate of hen lysozyme.
    van den Berg B; Chung EW; Robinson CV; Dobson CM
    J Mol Biol; 1999 Jul; 290(3):781-96. PubMed ID: 10395829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.
    Morozova-Roche LA; Zurdo J; Spencer A; Noppe W; Receveur V; Archer DB; Joniau M; Dobson CM
    J Struct Biol; 2000 Jun; 130(2-3):339-51. PubMed ID: 10940237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific hydrogen exchange of proteins: insights into the structures of amyloidogenic intermediates.
    Yao ZP; Tito P; Robinson CV
    Methods Enzymol; 2005; 402():389-402. PubMed ID: 16401516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oxidative refolding of hen lysozyme and its catalysis by protein disulfide isomerase.
    van den Berg B; Chung EW; Robinson CV; Mateo PL; Dobson CM
    EMBO J; 1999 Sep; 18(17):4794-803. PubMed ID: 10469657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the kinetics of S-S bond, secondary structure, and active site formation during refolding of reduced denatured hen egg white lysozyme.
    Roux P; Ruoppolo M; Chaffotte AF; Goldberg ME
    Protein Sci; 1999 Dec; 8(12):2751-60. PubMed ID: 10631992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
    Booth DR; Sunde M; Bellotti V; Robinson CV; Hutchinson WL; Fraser PE; Hawkins PN; Dobson CM; Radford SE; Blake CC; Pepys MB
    Nature; 1997 Feb; 385(6619):787-93. PubMed ID: 9039909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the structure of the denatured state of lysozyme on the aggregation reaction at the early stages of folding from the reduced form.
    Ohkuri T; Shioi S; Imoto T; Ueda T
    J Mol Biol; 2005 Mar; 347(1):159-68. PubMed ID: 15733925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
    J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure.
    De Felice FG; Vieira MN; Meirelles MN; Morozova-Roche LA; Dobson CM; Ferreira ST
    FASEB J; 2004 Jul; 18(10):1099-101. PubMed ID: 15155566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proline inhibits aggregation during protein refolding.
    Samuel D; Kumar TK; Ganesh G; Jayaraman G; Yang PW; Chang MM; Trivedi VD; Wang SL; Hwang KC; Chang DK; Yu C
    Protein Sci; 2000 Feb; 9(2):344-52. PubMed ID: 10716186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris.
    Kumita JR; Johnson RJ; Alcocer MJ; Dumoulin M; Holmqvist F; McCammon MG; Robinson CV; Archer DB; Dobson CM
    FEBS J; 2006 Feb; 273(4):711-20. PubMed ID: 16441658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysozyme refolding with cyclodextrins: structure-activity relationship.
    Desai A; Lee C; Sharma L; Sharma A
    Biochimie; 2006 Oct; 88(10):1435-45. PubMed ID: 16737767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of pH-sensitive polymer-assisted protein refolding and its application in TGF-beta1 and KGF-2.
    Huang Z; Ni C; Zhou X; Liu Y; Tan Y; Xiao J; Feng W; Li X; Yang S
    Biotechnol Prog; 2009; 25(5):1387-95. PubMed ID: 19598268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and aberrant biological self-assembly: Insights from studies of human lysozyme and its amyloidogenic variants.
    Dumoulin M; Kumita JR; Dobson CM
    Acc Chem Res; 2006 Sep; 39(9):603-10. PubMed ID: 16981676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved folding pathways of alpha-lactalbumin and lysozyme revealed by kinetic CD, fluorescence, NMR, and interrupted refolding experiments.
    Schlepckow K; Wirmer J; Bachmann A; Kiefhaber T; Schwalbe H
    J Mol Biol; 2008 May; 378(3):686-98. PubMed ID: 18377934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the unstructured intermediates in oxidative folding.
    Narayan M; Welker E; Scheraga HA
    Biochemistry; 2003 Jun; 42(23):6947-55. PubMed ID: 12795589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refolding kinetics of denatured-reduced lysozyme in the presence of folding aids.
    Dong XY; Huang Y; Sun Y
    J Biotechnol; 2004 Oct; 114(1-2):135-42. PubMed ID: 15464607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate enhancement of the oxidative folding of lysozyme by the use of aromatic thiol containing redox buffers.
    Gurbhele-Tupkar MC; Perez LR; Silva Y; Lees WJ
    Bioorg Med Chem; 2008 Mar; 16(5):2579-90. PubMed ID: 18065232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.